Workflow
鹰瞳抗压能力检测仪
icon
Search documents
鹰瞳科技-B发布中期业绩 期内溢利44.3万元 同比扭亏为盈
Zhi Tong Cai Jing· 2025-08-28 15:30
Core Insights - Eagle Eye Technology-B (02251) reported a mid-term performance for the six months ending June 30, 2025, with revenue of 83.713 million RMB, a gross profit of 64.103 million RMB, and a net profit of 0.443 million RMB, marking a turnaround from a loss of 81.488 million RMB in the same period last year [1] Group 1: Financial Performance - Revenue for the reporting period was 83.713 million RMB, with a gross profit of 64.103 million RMB, reflecting a year-on-year increase of 13.53% [1] - The company achieved a net profit of 0.443 million RMB, compared to a loss of 81.488 million RMB in the previous year, indicating a significant turnaround [1] Group 2: Product and Service Expansion - The number of active service points for the retinal detection AI products increased from 5,950 to 7,180, representing a year-on-year growth of 20.7% [1] - The usage of myopia prevention AI products reached 2.812 million times, a year-on-year increase of 68.1%, with the company establishing a distribution service system and star store service system for the PBM-LED myopia treatment device [1] - The visual training AI products recorded 1.026 million training sessions, showing a year-on-year growth of 11.6% [1] Group 3: New Product Development - The company successfully developed and launched a new generation of physiological stress capacity detection product, the "Eagle Eye Stress Capacity Detector," based on wireless sensing technology and multimodal AI algorithms, which has completed product finalization and market testing [1]
鹰瞳科技-B(02251)发布中期业绩 期内溢利44.3万元 同比扭亏为盈
智通财经网· 2025-08-28 15:28
Financial Performance - The company reported a revenue of 83.713 million RMB for the six months ending June 30, 2025, with a gross profit of 64.103 million RMB, representing a year-on-year increase of 13.53% [1] - The net profit for the period was 0.443 million RMB, a significant turnaround from a loss of 81.488 million RMB in the same period last year [1] Product and Service Expansion - The number of active service points for the retinal detection AI products increased from 5,950 to 7,180, marking a year-on-year growth of 20.7% [1] - The company detected 3.3 million cases through SaMD and health risk assessment solutions, reflecting an 11.4% year-on-year increase [1] - The usage of myopia prevention AI products reached 2.812 million times, a substantial growth of 68.1% year-on-year [1] - The visual training AI products recorded 1.026 million training sessions, which is an 11.6% increase compared to the previous year [1] New Product Development - The company successfully developed and launched a new generation of physiological stress capacity detection product, the "Eagle Eye Stress Capacity Detector," based on wireless sensing technology and multimodal AI algorithms, which has completed product finalization and market testing [2]
好博会必打卡!三款“神器”将亮相,檀健次、张雨绮都被圈粉!
新浪财经· 2025-05-29 00:37
Core Viewpoint - Eagle Eye Technology is introducing innovative health detection devices that aim to enhance personal health monitoring and management, making advanced medical technology accessible to households [2][3]. Group 1: Eagle Eye Technology Products - The company has developed three key products: an AI-based retinal camera for diabetes prediction, a stress detection device that operates in 90 seconds, and a vision rehabilitation device that surpasses traditional OK lenses [2][3][15]. - The AI retinal camera, AI-FD 16U, can automatically detect 35 types of retinal diseases and assess risks for 10 chronic conditions, achieving over 96% accuracy based on a clinical study involving 390,000 individuals [13][11]. - The stress detection device utilizes AI algorithms to evaluate users' stress levels and autonomic nervous system capabilities, providing results that are 1.6 times more accurate than traditional methods [6][8]. Group 2: Market Position and Future Prospects - Eagle Eye Technology's products are positioned to disrupt traditional medical practices by offering portable and user-friendly alternatives, with the AI retinal camera expected to be available for around 5,000 yuan for home use, allowing for 250 tests [13][18]. - The PBM-LED vision rehabilitation device is anticipated to reduce costs from approximately 2,000 USD to a more accessible price point within 3-5 years, broadening its market reach among youth [15][18]. - The company will showcase its products at the upcoming "Beautiful Life Expo" in Beijing, aiming to connect with consumers and enhance brand visibility [20][18].